Expression of Raf-1 Kinase Inhibitory Protein in Extrahepatic Bile Duct Carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background : Raf-1 kinase inhibitory protein (RKIP) recently has been identified as a metastasis suppressor in a variety of human carcinomas. The prognostic significance of RKIP expression in extrahepatic bile duct (EBD) carcinoma has not been studied. The aims of the current study were to evaluate RKIP expression and to determine the prognostic significance of RKIP expression in EBD carcinoma. Methods : Immunohistochemical staining for RKIP was performed for 131 cases of EBD carcinoma. The associations of RKIP expression with clinicopathologic parameters and patient outcomes were examined. Multivariate logistic regression analysis was used to identify independent predictive parameters for lymphovascular invasion and nodal and distant metastases. Results : Loss of RKIP expression was observed in 55.0% (72/131) of cases. EBD carcinoma had significantly lower RKIP immunoreactivity than normal EBD (p < 0.001). Loss of RKIP expression was significantly associated with lymphatic invasion (p = 0.030) and nodal metastasis (p = 0.036), but it was not found to be a significant prognostic predictor for overall, disease-free or distant metastasis-free survival. In addition, loss of RKIP expression was an independent predictor for lymphatic invasion (p = 0.027). Conclusions : These results suggest that RKIP may play a role in the suppression of lymphatic invasion and nodal metastasis in EBD carcinoma.
Abstract
Background : Raf-1 kinase inhibitory protein (RKIP) recently has been identified as a metastasis suppressor in a variety of human carcinomas. The prognostic significance of RKIP expression in extrahepatic bile duct (EBD) carcinoma has not been studied. The aims of the current study were to evaluate RKIP expression and to determine the prognostic significance of RKIP expression in EBD carcinoma. Methods : Immunohistochemical staining for RKIP was performed for 131 cases of EBD carcinoma. The associations of RKIP expression with clinicopathologic parameters and patient outcomes were examined. Multivariate logistic regression analysis was used to identify independent predictive parameters for lymphovascular invasion and nodal and distant metastases. Results : Loss of RKIP expression was observed in 55.0% (72/131) of cases. EBD carcinoma had significantly lower RKIP immunoreactivity than normal EBD (p < 0.001). Loss of RKIP expression was significantly associated with lymphatic invasion (p = 0.030) and nodal metastasis (p = 0.036), but it was not found to be a significant prognostic predictor for overall, disease-free or distant metastasis-free survival. In addition, loss of RKIP expression was an independent predictor for lymphatic invasion (p = 0.027). Conclusions : These results suggest that RKIP may play a role in the suppression of lymphatic invasion and nodal metastasis in EBD carcinoma.
참고문헌 (25)
- Welch DR, "What defines a useful marker of metastasis in human cancer?", J Natl Cancer Inst, 91, pp.1351~1353 (1999)
- Smith SC, "Learning therapeutic lessons from metastasis suppressor proteins", Nat Rev Cancer, 9, pp.253~264 (2009)
- Yoshida BA, "Metastasis-suppressor genes:a review and perspective on an emerging field", J Natl Cancer Inst, 92, pp.1717~1730 (2000)
- Schuierer MM, "Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines", Cancer Res, 64, pp.5186~5192 (2004)
- Minoo P, "Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer", Am J Clin Pathol, 127, pp.820~827 (2007)
- Li HZ, "Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer", Mol Cancer Res, 7, pp.832~840 (2009)
- Hagan S, "Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis", Clin Cancer Res, 11, pp.7392~7397 (2005)
- Fu Z, "Metastasis suppressor gene Raf kinase inhibitor protein(RKIP)is a novel prognostic marker in prostate cancer", Prostate, 66, pp.248~256 (2006)
- Chen Y, "Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis", J Proteome Res, 7, pp.5254~5262 (2008)
- Perry AC, "Sequence analysis of a mammalian phospholipid-binding protein from testis and epididymis and its distribution between spermatozoa and extracellular secretions", Biochem J, 301, pp.235~242 (1994)
- Serre L, "Crystal structures of YBHB and YBCL from Escherichia coli,two bacterial homologues to a Raf kinase inhibitor protein", J Mol Biol, 310, pp.617~634 (2001)
- Yeung K, "Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP", Nature, 401, pp.173~177 (1999)
- Yeung K, "Mechanism of suppression of the Raf", MEK, Mol Cell Biol, pp.2000, 20[DOI]
- Fu Z, "Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis", J Natl Cancer Inst, 95, pp.878~889 (2003)
- Al-Mulla F, "Raf kinase inhibitor protein:mechanism of loss of expression and association with genomic instability", J Clin Pathol, 61, pp.524~529 (2008)
- Al-Mulla F, "Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients", J Clin Oncol, 24, pp.5672~5679 (2006)
- Hoshino R, "Constitutive activation of the 41-", 43-kDa mitogen-activated protein kinase signaling pathway in human tumors, 1999, pp.18, 813~822
- Kajanne R, "EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways", J Cell Physiol, 212, pp.489~497 (2007)
- McCawley LJ, "Sustained activation of the mitogen-activated protein kinase pathway:a mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration", J Biol Chem, 274, pp.4347~4353 (1999)
- Klemke RL, "Regulation of cell motility by mitogen-activated protein kinase", J Cell Biol, 137, pp.481~492 (1997)
- Lorenz K, "Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2", Nature, 426, pp.574~579 (2003)
- Beach S, "Snail is a repressor of RKIP transcription in metastatic prostate cancer cells", Oncogene, 27, pp.2243~2248 (2008)
- Salameh A, "Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation,migration,and survival of endothelial cells through the activation of ERK,AKT,and JNK pathways", Blood, 106, pp.3423~3431 (2005)
- Kim BH, "Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas", Arch Pathol Lab Med, 131, pp.923~930 (2007)
- Chatterjee D, "Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients:implications for clinical outcome", Clin Cancer Res, 14, pp.2994~3001 (2008)